In the four years since the British singer last released an album, artists like Sombr, working in similar aesthetic modes, have climbed onto the charts.

President Trump’s simple campaign promise, now reality, includes lots of fine print that is confounding taxpayers and companies this filing season.

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.